Hereditary disorders mimicking and/or causing premature osteoarthritis

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 2, 2000, Pages 219-250

  Bálint, Géza ^a   Szebenyi, Béla ^a  

^a NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

Author keywords

Familial chondrocalcinosis; Hereditary osteochondrodysplasias; Ochronosis; Premature osteoarthritis; Wilson's disease

Indexed keywords

COLLAGEN; COPPER; GLYCOSAMINOGLYCAN; HOMOGENTISIC ACID; MATRIX PROTEIN;

ALKAPTONURIA; ARTHROPATHY; ARTICULAR CARTILAGE; BIOMECHANICS; CARTILAGE; CHONDRODYSPLASIA; COXA VARA; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FUTUROLOGY; GENE MUTATION; GENE THERAPY; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; INBORN ERROR OF METABOLISM; JOINT CAPSULE; OSTEOARTHRITIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TENDON; VARUS KNEE; WILSON DISEASE;

EID: 0343496973     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0063     Document Type: Article

References (130)

1. Harris W H. Etiology of osteoarthritis of the hip. Clinical Orthopaedics and Related Research. 213:1986;20-33.
2. Rubinstein H M. Thiemann's disease. Arthritis and Rheumatism. 18:1975;357-360.
3. Wynne-Davies R, Hall C, Ansell B M. Spondyloepiphyseal dysplasia tarda with progressive arthropathy. A 'new' disorder of autosomal recessive inheritence. Journal of Bone and Joint Surgery. 64B:1982;442-445.
4. Bahabri S A, Suwairi W M, Laxer R M. The camptodactily-arthropathy-coxa vara-pericarditis syndrome. Arthritis and Rheumatism. 41:1998;730-735.
5. Stremmel W, Meyerrose K W, Niderau C. Wilson disease: clinical presentation, treatment and survival. Annals of Internal Medicine. 115:1991;720-726.
6. Crawley A C, Niedzielski K H, Isaac E I. Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI. Journal of Clinical Investigation. 99:1997;651-662.
7. Berthet F, Siegrist C A, Orsahin H. Bone marrow transplantation in cartilage-hair hypoplasia: correction of immunodeficiency but not of the chondrodysplasia. European Journal of Pediatrics. 155:1996;286-290.
8. Stronchen D F, Hubel A, Shankar S R. Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidoses type II. Hunter's syndrome. Blood Components. 39:1999;343-350.
9. Barranger I A, Rice E O, Swaney W P. Gene transfer approaches to lysosomal storage disorders. Neurochemical Research. 24:1999;601-615.
10. Hunziker E B. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable? Osteoarthritis and Cartilage. 7:1999;15-28.
11. Ahsan T, Sah R L. Biomechanics of integrative cartilage repair. Osteoarthritis and Cartilage. 7:1999;29-40.
12. Hangody L, Szerb I, Sükösd L. Cartilage and chondrocyte transplantation and current concept of cartilage repair. APLAR Journal of Rheumatology. 2:1998;179-185.
13. European Journal of Pediatrics. 151:1992;407-415.
14. Williams C J, Jimenez S A. Heritable diseases of cartilage caused by mutations in collagen genes. Journal of Rheumatology. 22:1995;28-33.
15. Rivaniemi P, Korkko I, Bonaventure J. Identification of COL2A1 gene mutations with chondrodysplasias and familial osteoarthritis. Arthritis and Rheumatism. 38:1995;999-1004.
16. Deere M, Sanford T, Francomano C A. Identification of nine novel mutations in cartilage oligometric matrix proteins in patients with pseudochondroplasia on multiple epiphyseal dysplasia. American Journal of Medical Genetics. 85:1999;486-490.
17. Shiang R, Thompson L M, Zhu Y Z. Mutation of the transmembrane domain of FGFR3 causes the most common genetic form of dwarfism, achondroplasia. Cell. 78:1994;335-342.
18. Neufeld E F, Muenzer J. Mucopolysaccharidoses. Scriver C R, Beaudet A L, Sly W S, Valle D. The Metabolic and Molecular Basis of Inherited Diseases. 1995;2465-2494 McGraw-Hill, New York.
19. Ikegawa S, Nishimura G, Nagal T. Mutation of type X collagene gene (COLIOA1) causes spondylometaphyseal dysplasia. American Journal of Human Genetics. 63:1998;1659-1662.
20. Spranger J. The type XI collagenopathies. Pediatric Radiology. 28:1998;745-750.
21. Nakata K, Ono K, Miyazak J. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing aI(IX) collagen chains with a central detection. Proceedings of the National Academy of Sciences of the USA. 90:1993;2870-2874.
22. Nissenson R A. Parathyroid hormone (PTH)/OTHrP receptor mutation in human chondroplasia. Endocrinology. 139:1998;4753-4755.
23. Karaplis A C, He B, Nguyen M TA. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondroplasia. Endocrinology. 139:1998;5255-5258.
24. Schipani E, Langman C B, Parfitt A M. Constitutively active receptors for parathyroid hormone and parathyroid hormone related peptide in Jansen's metaphyseal chrondrodysplasia. New England Journal of Medicine. 335:1996;708-714.
25. Farfel Z, Bourne H R, Iiri T. The expanding spectrum of G protein diseases. New England Journal of Medicine. 340:1999;1012-1018.
26. Cicuttini F M, Spector T D. What is the evidence that osteoarthritis is genetically determined? Baillière's Clinical Rheumatology. 11:1997;657-669.
27. British Medical Journal. 312:1996;943-944.
28. Spector T D, Cicuttini F, Baker J, Hart D J. Genetic influences on osteoarthritis in women: a twin study. British Medical Journal. 312:1996;940-944.
29. MacGregor A J, Spector T D. Twins and the genetic architectures of osteoarthritis. Rheumatology. 38:1999;583-588.
30. Wright G D, Hughes A E, Reagan M, Doherty M. Association of two loci on chromosome 2q with nodal osteoarthritis. Annals of the Rheumatic Diseases. 55:1996;317-319.
31. Keen R W, Hart D J, Lanchbury J S, Spector T D. Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene. Arthritis and Rheumatism. 40:1997;1444-1449.
32. Whitfield W F. Chondrodysplasia punctata after warfarin in early pregnancy. Archives of Disease in Childhood. 55:1980;139-142.
33. Stressguth A P, Clarren S K, Jones K L. Natural history of the fetal alcohol syndrome: a 10 year follow up of 11 patients. Lancet. ii:1985;85-86.
34. Elcioglu N, Hall C M. Maternal systemic lupus erythematosus and chrondrodysplasia punctata in two sibs: phenocopy of coincidence? Journal of Medical Genetics. 35:1998;690-696.
35. Wordsworth P. Genes and arthritis. British Medical Bulletin. 51:1995;249-266.
36. Oberklaid F, Danks D M, Jensen F. Achondroplasia and hyphochondroplasia. Comments on frequency, mutation rate and radiological features in skull and spine. Journal of Medical Genetics. 16:1979;140-146.
37. McKusic V S. Heritable Disorders of Connective Tissue. 1972;CV Mosby, St Louis.
38. Spranger J W, Langer L O, Widemann H R. Bone Dysplasias. An Atlas of Constitutional Disorders of Skeletal Development. 1974;G Fisher/WB Saunders, Stuttgart.
39. Wynne-Davies R. Atlas of Skeletal Dysplasias. 1985;Churchill Livingstone, Edinburgh.
40. Wiedemann H R, Kunze I, Grosse F R, Dibbern H. An Atlas for Clinical Syndromes. 1992;Mosby/Wolfe, London.
41. Maroteaux P. Les maladies osseuses de l'enfant. 1982;Flammarion, Paris.
42. Bailey J A. Disproportionate Short Stature: Diagnosis and Management. 1974;WB Saunders, Philadelphia.
43. McAlister W H, Hermann T E. Osteochondrodysplasias, dysostoses, chromosomal aberrations, mucopolysaccharidoses, and mucolipidoses. Resnik D. Diagnosis of Bone and Joint Disorders. 1995;4163-4244 WB Saunders, Philadelphia.
44. Resnik D, Niwayama G. Calcium pyrophosphate dihydrate (CPPD) and crystal deposition disease. Resnik D. Diagnosis of Bone and Joint Disorders. 1995;1556-1614 WB Saunders, Philadelphia.
45. Spranger J. The epiphyseal dysplasias. Clinical Orthopaedics and Related Research. 114:1976;45-59.
46. Ikegawa S, Okashi H, Nishimura G. Novel and recurrent COMP (cartilage oligomeric matrix protein) matiation in pseudochondroplasia and multiple epiphyseal dysplasia. Human Genetics. 103:1998;633-638.
47. Treble N J, Jensen F O, Bankier A. Development of the hip in multiple epiphyseal dysplasia. Journal of Bone and Joint Surgery. 72B:1990;1061-1064.
48. Versteylen R J, Zwemmer A, Lovié C AM, Schuur K H. Multiple epiphyseal dysplasia complicated by severe osteochondritis dissecans of the knee. Skeletal Radiology. 17:1988;407-412.
49. Spranger J W, Langer L O, Wiedemann H R. Bone Dysplasias. 1974;G Fischer/WB Saunders, Stuttgart.
50. Matsui Y, Yasui N, Kimura T. Genotype phenotype correlation in achondroplasia and hypochondroplasia. Journal of Bone and Joint Surgery. 80B:1998;1052-1056.
51. Seiko Y, Morawake T, Tanaka H. Molecular defects in achondroplasia and the effects of growth hormone treatment. Acta Pediatrica. 88:1999;118-120.
52. Wilkin D J, Szabó J K, Cameron R. Mutations in fibroblast growth factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. American Journal of Human Genetics. 63:1998;711-716.
53. Young I D. Achondroplasia: a case of neglect? Lancet. 352:1998;1950-1951.
54. Hunter A GW, Bankier A, Rogers J G. Medical complications of achondroplasia: a multicentre patient review. Journal of Medical Genetics. 35:1998;705-712.
55. Ramaswami U, Hindermarsh P C, Brook C GD. Growth hormone therapy in hypochondroplasia. Acta Pediatrica. 88:1999;116-117.
56. Spranger J W, Langer L O. Spondyloepiphyseal dysplasia congenita. Radiology. 94:1970;313-322.
57. Anderson I J, Goldberg R B, Marion R W. Spondyloepiphyseal dysplasia congenita: genetic linkage to type II collagen (COL2A1). American Journal of Human Genetics. 46:1990;896-901.
58. Cole W G, Hall R K, Rogers J G. The clinical features of spondyloepiphyseal dysplasia congenita resulting from the substitution of glycine 997 by serine in the α1(II) clain type II collagen. Journal of Medical Genetics. 30:1993;27-38.
59. Langer L O. Spondyloepiphyseal dysplasia tarda. Radiology. 82:1964;833-839.
60. Whyte M P, Gottesman G S, Eddy M C, McAlister W H. X-linked recessive spondylopeiphyseal dysplasia tarda. Clinical and radiographic evolution in a 6-generation kindred and review of the literature. Medicine (Baltimore). 78:1999;9-25.
61. Silengo M C, Luzatti L. Clinical and genetic aspects of Conradi-Hünermann disease. Journal of Pediatrics. 97:1980;911-917.
62. Braverman N, Lin P, Moebius F F. Mutations in the gene encoding 3 betahydroxysteroid-delta 8m delta-7 isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nature Genetics. 22:1999;291-294.
63. Stickler G B, Balan B G, Farrel F J. Hereditary progressive arthroophthalmopathy. Mayo Clinic Proceedings. 40:1965;433-435.
64. Fernandes R J, Wilkin D J, Weiss M A. Incorporation of structurally defective type II collagen into cartilage matrix in Kniest chondroplasia. Archives of Biochemistry and Biophysics. 355:1998;282-290.
65. Baly T M, Okuyama T, Vogler C. Neonatal intramuscular injection with recombinant eden-associated virus results in prolonged β-glukuronidase expression in situ, and correction of liver pathology in mucopolysaccharidosis type mice. Human Gene Therapy. 10:1999;85-94.
66. Hoogenbrugge P M, Bruwer O F, Bordigani P. Allogeneic bone marrow transplantation for lysosomal storage disease. Lancet. 345:1995;398-1402.
67. Fleming D R, Henslee-Downey P J, Ciocci G. The use of partially HLA-mismatched donors for allogeneic transplantations with mucopolysaccharidosis, I. Pediatric Transplantation. 4:1998;299-304.
68. Herskhovitz E, Young J, Rainer C M. Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long term follow up. Journal of Inheritable Metabolic Diseases. 22:1999;50-62.
69. Haddad F S, Jones D HA, Velladi A. Carpal tunnel syndrome in the mucosaccharidoses and mucolipidoses. Journal of Bone and Joint Surgery. 97B:1997;576-582.
70. McLaughlin S H, Conn S N, Bulleid N J. Folding and assembly of type X collagen mutants that cause metaphyseal chondrodysplasia-type Schmid. Journal of Biological Chemistry. 274:1999;7570-7575.
71. Mäkitie O. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. Journal of Medical Genetics. 29:1992;652-655.
72. Mäkitie O, Kaitila I, Savilakti E. Susceptibility to infections and in vitro immuno-functions in cartilage hair hypoplasia. European Journal of Pediatrics. 157:1998;816-820.
73. Cederbaum S D, Kaitila I, Rimoin D L, Stiehm E R. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. Journal of Pediatrics. 89:1976;737-742.
74. Rateck H, Greco M A, Galb G. Pathologic findings in adenosine deaminase deficient severe combined immunodeficiency. 1. Kidney, adrenal and chondroosseus alterations. American Journal of Pathology. 120:1985;157-160.
75. Chakravarti V S, Borns P, Lobell J, Douglas S D. Chondrosseus dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency. Pediatric Radiology. 21:1991;447-448.
76. Formicola V. X-linked hypophosphatemic rickets. A probably upper paleolithic case. American Journal of Physical Anthropology. 98:1995;403-409.
77. Econs M J, McEnery P T, Lennon F, Speer M C. Autosomal dominant hypophosphatemic rickets is linked to chromosome 12p13. Journal of Clinical Investigation. 100:1997;2653-2657.
78. Ehrich J H, Berndt M, Lazivic D. Clinical course of hypophosphatemic rickets in 23 adults. Clinical Nephrology. 45:1996;33-41.
79. Radó J P, Haris Á, Szebenyi B. Successful treatment of familial X-linked hypophosphatemic osteomalacia with phosphate and high dose calcitriol. European Journal of Internal Medicine. 9:1998;185-186.
80. Silve C. Hereditary hypophosphatasia and hyperphosphatasia. Current Opinion in Rheumatology. 6:1994;336-339.
81. Goseki-Sone M, Orimo H, Iimura H. Expression of the mutant (1735T-DEL) tissue-nonspecific alkaline phosphatase gene from hypophosphatasia patients. Journal of Bone and Mineral Research. 13:1998;1827-1834.
82. Zurutuza L, Müller F, Gibrat J F. Correlations of genotype and phenotype in hypophosphatasia. Human Molecular Genetics. 8:1999;1039-1046.
83. Molloy M G, Hamilton E BD. Thiemann's disease. Rheumatology and Rehabilitation. 17:1978;179-180.
84. Handa R, Aggrawal P, Wali J P. A young boy with deforming arthropathy. Annals of the Rheumatic Diseases. 57:1998;79-80.
85. Athreya B H, Schumacher H R. Pathologic features of familial arthropathy associated with congenital flexion contractures of the fingers. Arthritis and Rheumatism. 21:1978;429-437.
86. Yerma U N, Misra R, Radhakrisnan S. A syndrome with infantile contractures of fingers and toes in 2 sisters, 'familial fibrosing serositis'. Journal of Rheumatology. 22:1995;2349-2355.
87. Kaibara N, Takagishi K, Katsuki I. Spondyloepiphyseal dysplasia tarda with progressive arthropathy. Skeletal Radiology. 10:1983;13-16.
88. Fischer J, Urtizberea J A, Pavek S. Genetic linkage of progressive pseudorheumatoid dysplasia to a 3cM internal of chromosome 6q22. Human Genetics. 103:1998;60-64.
89. el-Shanti H, Murray J C, Semina E V. Assignment of gene responsible for progressive pseudorheumatoid dysplasia to chromosome 6 and examination of COL10A1 as candidate gene. European Journal of Human Genetics. 6:1998;251-256.
90. el-Shanti H E, Omari H Z, Qubain H I. Progressive pseudorheumatoid dysplasia: report of a family and review. Journal of Medical Genetics. 34:1997;559-563.
91. Raman D, Haslock I. The nail-patella syndrome. A report of two cases and literature review. British Journal of Rheumatology. 22:1983;41-46.
92. McIntosh I, Dreyer S D, Clough M V. Mutation analysis of LMX1B gene in nail-patella syndrome patients. American Journal of Human Genetics. 63:1998;1651-1658.
93. Mangino M, Sanchez O, Torente I. Localization of a gene for familial patella aplasia-hypoplasia (PTLAH) to chromosome 17q21-22. American Journal of Human Genetics. 65:1999;441-447.
94. Garrod A E. The incidence of alkaptonuria: a study in clinical individuality. Lancet. 2:1902;1616-1620.
95. Garrod A E. The Croonian Lectures on inborn errors of metabolism. Lecture II. Alkaptonuria. Lancet. 2:1908;73-79.
96. La Du B N, Zannoni V G, Laster L. The nature of the defect in tyrosine metabolism in alkaptonuria. Journal of Biological Chemistry. 230:1958;251-260.
97. Janocha S, Wolz W, Srsen S. The human gene for alkaptonuria (aku) maps to chromosome 3q. Genomics. 19:1994;5-8.
98. Granadino B, Beltrán-Valero de Bernabé D, Fernández-Canon J M. The human homogentisate (HGO) gene. Genomics. 43:1997;115-122.
99. Beltrán-Valero de Bernabé D, Granadino B, Chiarelli O. Mutation and polymorphism analysis of the human homogentisate 1,2-dioxygenase gene in alkoptonuria patients. American Journal of Human Genetics. 62:1998;776-784.
100. Felber U, Mutsch Y, Grehn F. Ocular ochronosis in alkaptonuria patients carrying mutations in the homogentisate 1,2-dioxygenase gene. British Journal of Ophthalmology. 83:1999;680-683.
101. Konttinen Y T, Hoikka V, Landtman M. Ochronosis: a report of a case and a review of literature. Clinical and Experimental Rheumatology. 7:1989;435-444.
102. Fishet A A. Exogenous ochronosis from hydroquinone bleaching cream. Cutis. 162:1998;11-12.
103. O'Brien W M, Banfield W C, Sokoloff L. Studies on the pathogenesis of ochronotic arthropathy. Arthritis and Rheumatism. 4:1961;137-152.
104. Srsen S, Cisarik F, Pasztor L. Alkaptonuria in the Trencin district of Czechoslowakia. American Journal of Medical Genetics. 2:1978;159-166.
105. Milch R A. Studies of alkaptonuria: inheritance of 47 cases in eight highly inter-related Dominican kindreds. American Journal of Human Genetics. 12:1960;76-85.
106. Wells C, Maxwell B M. Alkaptonuria in an Egyptian mummy. British Journal of Radiology. 35:1962;679-682.
107. O'Brien W M, La Du B N, Bunim J J. Biochemical, pathological and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584-1962). American Journal of Medicine. 34:1963;813-838.
108. La Du B N. Alkaptonuria. Scriver C R, Beaudet A L, Sly W, Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;1371-1386 McGraw-Hill, New York.
109. Skinsnes O K. Generalized ochronosis. Report of an instance in which it was misdiagnosed as melanosarcoma, with resultant enucleation of an eye. Archives of Pathology. 45:1948;552-558.
110. Mckenzie C R, Major P, Hunter T. Tendon involvement in a case of ochronosis. Journal of Rheumatology. 9:1982;634-636.
111. Hüttl S. Synovial effusion: A nosographic and diagnostic study. Part I. Acta Rheumatica Balneologica Pistiniana. 5:1970;1-100.
112. Hunter T, Gordon D A, Ogryzlo M A. The ground pepper sign of synovial fluid: a new diagnostic feature of ochronosis. Journal of Rheumatology. 1:1974;45-53.
113. Anikster Y, Nyhan W L, Gahl W A. NTBC and alkaptonuria. American Journal of Human Genetics. 62:1998;765-767.
114. La Du B N. Are we ready to try to cure alkaptonuria? American Journal of Human Genetics. 62:1998;765-767.
115. Montagutelli X, Lalouette A, Coudé M. AKU, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16. Genomics. 19:1994;9-11.
116. Schmidt S R, Gehrig A, Koehler M R. Cloning of the homogentisate 1,2-dioxygenase gene, the key enzyme of alkaptonuria in mouse. Mammalian Genome. 8:1997;168-171.
117. Oh W J, Wim E K, Park K D. Cloning and characterization of promoter region of Wilson disease gene. Biochemical and Biophysical Research Communications. 259:1999;206-211.
118. Scheinberg H. Wilson's disease. Journal of Rheumatology. 8:1981;90-93.
119. Cordato D J, Fulham M J, Yiannakis C. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20 year old patient with Wilson's disease. Movement Disorders. 13:1998;162-166.
120. Feller E R, Schumacher H R. Osteoarticular changes in Wilson's disease. Arthritis and Rheumatism. 15:1972;259-266.
121. Menerey K A, Eider W, Brewer J G. The arthropathy of Wilson's disease: clinical and pathologic features. Journal of Rheumatology. 15:1988;331-337.
122. Walshe J M. Penicillamine, a new oral therapy for Wilson's disease. American Journal of Medicine. 21:1956;487-495.
123. Walshe J M, Yealland M. Chelation treatment of neurological Wilson's disease. Quarterly Journal of Medicine. 86:1993;197-204.
124. Brewer G J, Dick R D, Johnson V D. Treatment of Wilson's disease with zinc: long term follow up studies. Journal of Laboratory and Clinical Medicine. 132:1998;264-278.
125. Zitnan D, Sitaj S. Chondrocalcinosis articularis. Clinical and radiological study. Annals of the Rheumatic Diseases. 22:1963;142-152.
126. Rodrigez-Valverde V, Tinturé T, Zuniga M. Familial chondrocalcinosis. prevalence in Northern Spain and clinical features in five pedigrees. Arthritis and Rheumatism. 23:1980;471-478.
127. Doherty M, Hamilton E, Henderson J. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families. British Journal of Rheumatology. 30:1991;10-15.
128. Balsa A, Martin-Mola E, Gonzales T. Familial articular chondrocalcinosis in Spain. Annals of the Rheumatic Diseases. 49:1990;531-535.
129. Andrew L J, Brancolini V, de la Pena L S. Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease. American Journal of Human Genetics. 64:1999;136-145.
130. Smilde T J, Haverman J F, Schipper P. Familial hypokalemia/hypomagnesemia and chondrocalcinosis. Journal of Rheumatology. 21:1994;1515-1519.